Cite

HARVARD Citation

    Shinkai, M. et al. (2023). One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study. Journal of asthma. pp. 616-624. [Online]. 
  
Back to record